Table 1. Baseline characteristics of the study patients.
| All patients (n = 606) | LDL-C levels | ||||
| < 70 mg/dL (n =75) | 70 to < 100 mg/dL ( n = 194) | > 100 mg/dL (n = 337) | P value | ||
| Data are presented as n (%) or median (IQR). AIS: acute ischaemic stroke; COPD: chronic obstructive pulmonary disease; GLU: glucose; HDL-C: high-density lipoprotein cholesterol; IQR: interquartile range; LDL-C: low-density lipoprotein cholesterol; mRS: modified Rankin Scale; TCH: total cholesterol; TG: triglycerides; TIA: transient ischaemic attack. | |||||
| Age, yrs | 58 (49−68) | 62 (54−72) | 59 (50−68) | 57 (47−66) | 0.01 |
| Male | 420 (69%) | 52 (69%) | 134 (69%) | 234 (69%) | 0.10 |
| Prior mRS scores > 2 | 25 (4%) | 8 (11%) | 6 (3%) | 11 (3%) | 0.01 |
| Medical history | |||||
| Hypertension | 470 (78%) | 55 (73%) | 143 (74%) | 272 (81%) | 0.11 |
| Heart disease | 95 (16%) | 14 (19%) | 26 (13%) | 55 (16%) | 0.50 |
| Diabetes mellitus | 123 (20%) | 28 (38%) | 40 (21%) | 55 (16%) | < 0.01 |
| Previous AIS/TIA | 96 (16%) | 20 (27%) | 36 (19%) | 39 (12%) | < 0.01 |
| Previous ICH | 49 (8%) | 10 (13%) | 18 (9%) | 21 (6%) | 0.10 |
| COPD | 13 (2%) | 3 (4%) | 3 (2%) | 7 (2%) | 0.46 |
| Alcohol consumption | 225 (37%) | 28 (37%) | 59 (30%) | 138 (41%) | 0.05 |
| Pre-medications | |||||
| Statin | 60 (10%) | 10 (13%) | 23 (12%) | 27 (8%) | 0.21 |
| Antiplatelets | 76 (13%) | 14 (19%) | 26 (13%) | 36 (11%) | 0.15 |
| Anticoagulants | 6 (1%) | 0 (0%) | 1 (1%) | 5 (1%) | 0.36 |
| Anti-hypertensive | 344 (57%) | 45 (60%) | 105 (54%) | 194 (58%) | 0.62 |
| Laboratory data | |||||
| GLU, mg/dL | 101 (88−126) | 103 (94−146) | 102 (87−123) | 115 (88−126) | 0.23 |
| TG, mg/dL | 120 (89−168) | 103 (80−142) | 112 (83−157) | 128 (96−192) | < 0.01 |
| TCH, mg/dL | 172 (146−198) | 117 (105−132) | 150 (139−163) | 193 (177−218) | < 0.01 |
| HDL-C, mg/dL | 47 (39−56) | 39 (31−51) | 46 (37−55) | 49 (42−58) | < 0.01 |